FMO2
protein-codingflavin containing dimethylaniline monoxygenase 2, the group of Flavin containing monooxygenases
Gene summary
This gene encodes a flavin-containing monooxygenase family member. It is an NADPH-dependent enzyme that catalyzes the N-oxidation of some primary alkylamines through an N-hydroxylamine intermediate. However, some human populations contain an allele (FMO2*2A) with a premature stop codon, resulting in a protein that is C-terminally-truncated, has no catalytic activity, and is likely degraded rapidly. This gene is found in a cluster with other related family members on chromosome 1. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2014]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~27.4 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
No GenCC data available for this gene.
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to FMO2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001460.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 2 | ||||
| missense | 69 | 5 | 74 | |||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 2 | 2 | ||||
| Total | 0 | 0 | 71 | 7 | 0 | 78 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001451.2 | 8 | MANE Select | |
| Ensembl | ENSP00000209929.8 | 8 | MANE Select | |
| RefSeq | NP_001288276.1 | 4 | Standard | |
| RefSeq | NP_001352829.1 | 7 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Drug metabolism - cytochrome P450 - Homo sapiens (human)
- Busulfan Pathway, Pharmacodynamics
- Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs)
- Metapathway biotransformation Phase I and II
- Phase I - Functionalization of compounds
Biological Process
- organic acid metabolic process
- NADP metabolic process
- xenobiotic metabolic process
- toxin metabolic process
- drug metabolic process
Molecular Function
- monooxygenase activity
- N,N-dimethylaniline monooxygenase activity
- flavin adenine dinucleotide binding
- NADP binding
Cellular Component
- endoplasmic reticulum membrane
- membrane
- organelle membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000441535
- Coding exons
- 8
- Length
- 27476
- Individuals with no LoFs
- 111898
- Homozygous LoFs
- 842
- Heterozygous LoFs
- 13007
- Defined
- 125747
- p
- 0.0567
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.0993 | 256 | 261 | 0.983 | 0.0000136 | 3111 |
| Missense (PolyPhen) | 86 | 98.658 | 0.8717 | 1233 | ||
| Synonymous | 0.567 | 85 | 91.9 | 0.925 | 0.00000486 | 876 |
| Loss of Function | 1.36 | 13 | 19.5 | 0.667 | 9.05e-7 | 260 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.29 | 0.29 | notable |
| Latino/Admixed American | 0.038 | 0.038 | notable |
| Ashkenazi Jewish | 0.090 | 0.090 | notable |
| East Asian | 0.00087 | 0.00087 | rare |
| Finnish | 0.024 | 0.024 | notable |
| European (Non-Finnish) | 0.048 | 0.048 | notable |
| South Asian | 0.053 | 0.053 | notable |
| Other | 0.053 | 0.053 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Catalyzes the N-oxidation of certain primary alkylamines to their oximes via an N-hydroxylamine intermediate. Inactive toward certain tertiary amines, such as imipramine or chloropromazine. Can catalyze the S-oxidation of methimazole. The truncated form is catalytically inactive. {ECO:0000269|PubMed:9804831}.;
Intolerance Scores
- LoFtool
- 0.941
- RVIS EVS
- 2.47
- RVIS percentile EVS
- 98.61
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.229
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | High | High | High |
| Primary Immunodeficiency | High | High | High |
| Cancer | High | High | High |